COMPANIES COVERED
Alnylam PharmaceuticalsDownload FREE Report Sample
Download Free sampleRNAi (Ribonucleic Acid Interference) a system in live cells to keep a check on the active genes is the next promising technology in the field of biotechnology. The major classes of RNAi are micro RNA and small interfering RNA. RNAi is said to be the replacement technology for the existing recombinant technology in the field of drug discovery and therapeutics.
RNAi Technologies Market contains market size and forecasts of RNAi Technologies in Global, including the following market information:
Global RNAi Technologies Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global RNAi Technologies market was valued at 310 million in 2021 and is projected to reach US$ 424.5 million by 2028, at a CAGR of 4.6% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oncology Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of RNAi Technologies include Alnylam Pharmaceuticals, Benitec Biopharma Ltd, Filmtec Corporation, Ionis Pharmaceuticals, Quark Pharmaceuticals Inc., RXI Pharmaceuticals, Qiagen, Invitrogen and Ambion. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the RNAi Technologies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global RNAi Technologies Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global RNAi Technologies Market Segment Percentages, by Type, 2021 (%)
Oncology
Ocular Disorders
Respiratory Disorders
Liver Diseases
Other
Global RNAi Technologies Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global RNAi Technologies Market Segment Percentages, by Application, 2021 (%)
Research
Therapeutics
Global RNAi Technologies Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global RNAi Technologies Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies RNAi Technologies revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies RNAi Technologies revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alnylam Pharmaceuticals
Benitec Biopharma Ltd
Filmtec Corporation
Ionis Pharmaceuticals
Quark Pharmaceuticals Inc.
RXI Pharmaceuticals
Qiagen
Invitrogen
Ambion
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
